News-Medical -- HTX today announced it is providing $248,750 in financing to Baylis Medical Company, a developer of innovative cardiology, endovascular, pain management, and orthopaedic devices. HTX financing will support the final development of a novel surgical device, including research-based evidence, enabling worldwide regulatory submissions, sales and marketing of the device.
“This minimally invasive device positions Baylis Medical well to address a growing market need and has the potential to create several high-quality jobs in product development, engineering, sales and marketing over the next few years,” said Frank Baylis, President of Baylis Medical.
